Corvus Pharmaceuticals, Inc. (CRVS) Reports Material Event to SEC
Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) filed a Form 8-K with the Securities and Exchange Commission on January 20, 2026, disclosing a material event. Corvus Pharmaceuticals,…
Read more
